The important role of RIPK1 kinase in the pathogenesis of COVID-19 has also been revealed by proteome-wide data analysis, which suggests RIPK1 as a promising drug target to rescue multiorgan injury and inflammation in COVID-19 [187]. Here, RIPK1 is linked to COVID-19.